193 related articles for article (PubMed ID: 11041271)
1. Non-serotonergic potentiation by (-)-pindolol of DOI-induced forward locomotion in rats: possible involvement of beta-adrenoceptors?
Kaur P; Ahlenius S
J Neural Transm (Vienna); 2000; 107(8-9):903-17. PubMed ID: 11041271
[TBL] [Abstract][Full Text] [Related]
2. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
Hillegaart V; Ahlenius S
Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
[TBL] [Abstract][Full Text] [Related]
3. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
4. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
[TBL] [Abstract][Full Text] [Related]
5. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.
Waldmeier PC; Williams M; Baumann PA; Bischoff S; Sills MA; Neale RF
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):609-20. PubMed ID: 2905765
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenoceptor blockade in rats enhances the ambulation induced by 5-HT1A receptor agonists.
Kalkman HO
Eur J Pharmacol; 1989 Dec; 173(2-3):121-5. PubMed ID: 2576226
[TBL] [Abstract][Full Text] [Related]
7. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
Misane I; Ogren SO
Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol pretreatment.
Kaur P; Ahlenius S
J Neural Transm (Vienna); 1997; 104(6-7):605-14. PubMed ID: 9444561
[TBL] [Abstract][Full Text] [Related]
9. Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5-HT1A receptors.
Lejeune F; Millan MJ
Eur J Neurosci; 2000 Sep; 12(9):3265-75. PubMed ID: 10998110
[TBL] [Abstract][Full Text] [Related]
10. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
Stenfors C; Yu H; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
[TBL] [Abstract][Full Text] [Related]
12. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
Hjorth S; Sharp T
J Pharmacol Exp Ther; 1993 May; 265(2):707-12. PubMed ID: 8098761
[TBL] [Abstract][Full Text] [Related]
13. The role of 5-hydroxytryptamine1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists.
Przegaliński E; Filip M; Chojnacka-Wójcik E; Tatarczyńska E
Pharmacol Biochem Behav; 1994 Apr; 47(4):873-8. PubMed ID: 7913223
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of 5-HT1A receptor ligands by drug discrimination.
Wolff MC; Leander JD
Eur J Pharmacol; 1997 Aug; 333(2-3):113-22. PubMed ID: 9314023
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1A agonist activity of pindolol: reversal of the inhibitory effects on cell firing in the dorsal raphe nucleus but not in the hippocampus by WAY-100,635.
Sprouse J; Braselton J; Reynolds L
Ann N Y Acad Sci; 1998 Dec; 861():274-5. PubMed ID: 9928287
[No Abstract] [Full Text] [Related]
16. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
17. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
Sánchez C; Mørk A
Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an involvement of 5-HT1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP.
Ahlenius S; Larsson K
Psychopharmacology (Berl); 1998 Jun; 137(4):374-82. PubMed ID: 9676898
[TBL] [Abstract][Full Text] [Related]
19. (-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.
Assie MB; Koek W
Neuropharmacology; 1996 Feb; 35(2):213-22. PubMed ID: 8734491
[TBL] [Abstract][Full Text] [Related]
20. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
Sugimoto Y; Kimura I; Watanabe Y; Yamada J
Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
